Related Experiment Video
Updated: May 28, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Poor response to treatment: beyond medication
1Professor of Psychiatry, Faculty of Medicine, Universiclacl de los Andes, and Hospital del Trabajador Santiago, Chile.
Dialogues in Clinical Neuroscience
|October 29, 2011
Summary
Patient adherence to psychiatric medication is crucial for treatment success. Integrating psychosocial interventions with pharmacological treatments can improve adherence and overall patient functioning in chronic mental health conditions.
Area of Science:
- Psychiatry
- Clinical Psychology
Background:
- Poor adherence to psychiatric medication is a significant barrier to effective treatment for chronic mental illnesses like schizophrenia and affective disorders.
- Noncompliance rates in maintenance treatments can exceed 50%, negatively impacting patient outcomes.
- Adherence issues stem from drug-related, patient-related, and physician-related factors.
Purpose of the Study:
- To review the concepts of adherence and noncompliance in psychiatric maintenance treatments.
- To examine the impact of noncompliance on treatment outcomes.
- To explore the role of psychosocial interventions in improving adherence and patient functioning.
Main Methods:
- Literature review of concepts related to treatment adherence and noncompliance in psychiatry.
- Analysis of factors contributing to poor adherence.
- Discussion of the integration of psychosocial treatments with pharmacotherapy.
Main Results:
- Noncompliance is multifactorial, influenced by medication properties, patient characteristics, and healthcare provider interactions.
- Psychosocial interventions, when combined with pharmacotherapy, are essential for enhancing adherence.
- Addressing psychosocial factors can lead to improved social, work, and family functioning.
Conclusions:
- Improving adherence through integrated treatment approaches is vital for managing chronic psychiatric conditions.
- Psychosocial support is a key component in optimizing medication effectiveness and patient well-being.
- A comprehensive approach addressing adherence barriers is necessary for better long-term psychiatric care.
Related Concept Videos
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Treatment Strategies for Psychological Disorders
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...